Amyloid-β đồng địa điểm với apolipoprotein B trong các tế bào hấp thụ của ruột non
Tóm tắt
Từ khóa
Tài liệu tham khảo
Glenner GG, Wong CW: Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984, 120 (3): 885-890. 10.1016/S0006-291X(84)80190-4
Park IH, Hwang EM, Hong HS, Boo JH, Oh SS, Lee J, Jung MW, Bang OY, Kim SU, Mook-Jung I: Lovastatin enhances Abeta production and senile plaque deposition in female Tg2576 mice. Neurobiol Aging. 2003, 24 (5): 637-643. 10.1016/S0197-4580(02)00155-0
Runz H, Rietdorf J, Tomic I, de Bernard M, Beyreuther K, Pepperkok R, Hartmann T: Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells. J Neurosci. 2002, 22 (5): 1679-1689.
Pallebage-Gamarallage MM, Galloway S, Johnsen R, Jian L, Dhaliwal S, Mamo JC: The effect of exogenous cholesterol and lipid-modulating agents on enterocytic amyloid-beta abundance. Br J Nutr. 2009, 101 (3): 340-347. 10.1017/S0007114508012269
Simons K, Ikonen E: How cells handle cholesterol. Science. 2000, 290 (5497): 1721-1726. 10.1126/science.290.5497.1721
Galloway S, Jian L, Johnsen R, Chew S, Mamo JC: beta-amyloid or its precursor protein is found in epithelial cells of the small intestine and is stimulated by high-fat feeding. J Nutr Biochem. 2007, 18 (4): 279-284. 10.1016/j.jnutbio.2006.07.003
Koudinov AR, Koudinova NV: Alzheimer's soluble amyloid beta protein is secreted by HepG2 cells as an apolipoprotein. Cell Biol Int. 1997, 21 (5): 265-271. 10.1006/cbir.1996.0126
Mamo JC, Jian L, James AP, Flicker L, Esselmann H, Wiltfang J: Plasma lipoprotein beta-amyloid in subjects with Alzheimer's disease or mild cognitive impairment. Ann Clin Biochem. 2008, 45 (Pt 4): 395-403. 10.1258/acb.2008.007214
Boyt AA, Taddei K, Hallmayer J, Mamo J, Helmerhorst E, Gandy SE, Martins RN: Relationship between lipid metabolism and amyloid precursor protein and apolipoprotein E. Alzheimer's Reports. 1999, 2: 339-346.
James AP, Pal S, Gennat HC, Vine DF, Mamo JCL: The incorporation and metabolism of amyloid-beta into chylomicron-like lipid emulsions. J Alzheimers Dis. 2003, 5: 179-188.
Golde TE, Eckman CB: Cholesterol modulation as an emerging strategy for the treatment of Alzheimer's disease. Drug Discov Today. 2001, 6 (20): 1049-1055. 10.1016/S1359-6446(01)01965-1
Koudinov A, Matsubara E, Frangione B, Ghiso J: The soluble form of Alzheimer's amyloid beta protein is complexed to high density lipoprotein 3 and very high density lipoprotein in normal human plasma. Biochem Biophys Res Commun. 1994, 205 (2): 1164-1171. 10.1006/bbrc.1994.2788
Zlokovic BV, Martel CL, Mackic JB, Matsubara E, Wisniewski T, McComb JG, Frangione B, Ghiso J: Brain uptake of circulating apolipoproteins J and E complexed to Alzheimer's amyloid beta. Biochem Biophys Res Commun. 1994, 205 (2): 1431-1437. 10.1006/bbrc.1994.2825
LaDu MJ, Pederson TM, Frail DE, Reardon CA, Getz GS, Falduto MT: Purification of apolipoprotein E attenuates isoform-specific binding to beta-amyloid. J Biol Chem. 1995, 270 (16): 9039-9042. 10.1074/jbc.270.16.9039
Shao H, Jao S-C, Ma K, Zagoriski MG: Solution Structures of Michelle-bound Amyloid beta1-40 and bet1-42 Peptides of Alzheimer's Disease. J Mol Biol. 1999, 285: 755-773. 10.1006/jmbi.1998.2348
Galloway S, Pallebage-Gamarallage MM, Takechi R, Jian L, Johnsen RD, Dhaliwal SS, Mamo JC: Synergistic effects of high fat feeding and apolipoprotein E deletion on enterocytic amyloid-beta abundance. Lipids Health Dis. 2008, 7: 15- 10.1186/1476-511X-7-15
Nelson TJ, Alkon DL: Protection against beta-amyloid-induced apoptosis by peptides interacting with beta-amyloid. J Biol Chem. 2007, 282 (43): 31238-31249. 10.1074/jbc.M705558200
Takechi R, Galloway S, Pallebage-Gamarallage MM, Johnsen RD, Mamo JC: Three-dimensional immunofluorescent double labelling using polyclonal antibodies derived from the same species: enterocytic colocalization of chylomicrons with Golgi apparatus. Histochem Cell Biol. 2008, 129 (6): 779-784. 10.1007/s00418-008-0404-0
Manders EMM, Verbeek FJ, Atenm JA: Measurement of co-localization of objects in dual-colour confocal images. J Microsc. 1993, 169 (3): 375-382.
Hussain MM, Kedees MH, Singh K, Athar H, Jamali NZ: Signposts in the assembly of chylomicrons. Front Biosci. 2001, 6: D320-331. 10.2741/Hussain
van Greevenbroek MM, de Bruin TW: Chylomicron synthesis by intestinal cells in vitro and in vivo. Atherosclerosis. 1998, 141 (Suppl 1): S9-16. 10.1016/S0021-9150(98)00212-3
Davidson NO, Kollmer ME, Glickman RM: Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J Lipid Res. 1986, 27 (1): 30-39.
Green PH, Riley JW: Lipid absorption and intestinal lipoprotein formation. Aust N Z J Med. 1981, 11 (1): 84-90.
Lee DM, Singh S: Degradation of apolipoprotein B-100 in human chylomicrons. Biochim Biophys Acta. 1988, 960 (2): 148-156.
Patil S, Sheng L, Masserang A, Chan C: Palmitic acid-treated astrocytes induce BACE1 upregulation and accumulation of C-terminal fragment of APP in primary cortical neurons. Neurosci Lett. 2006, 406 (1-2): 55-59. 10.1016/j.neulet.2006.07.015
LaRue B, Hogg E, Sagare A, Jovanovic S, Maness L, Maurer C, Deane R, Zlokovic BV: Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice. J Neurosci Methods. 2004, 138 (1-2): 233-242. 10.1016/j.jneumeth.2004.04.026
Burgess BL, McIsaac SA, Naus KE, Chan JY, Tansley GH, Yang J, Miao F, Ross CJ, van Eck M, Hayden MR: Elevated plasma triglyceride levels precede amyloid deposition in Alzheimer's disease mouse models with abundant A beta in plasma. Neurobiol Dis. 2006, 24 (1): 114-127. 10.1016/j.nbd.2006.06.007
Takechi R, Galloway S, Pallebage-Gamarallage MMS, Wellington CL, Johnsen RD, Dhaliwal SS, Mamo JCL: Differential effects of dietary fatty acids on the cerebral distribution of plasma derived apo B lipoproteins with amyloid-beta. Br J Nutr. 2009.